메뉴 건너뛰기




Volumn 21, Issue 27-30, 2003, Pages 4348-4358

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus

Author keywords

Adjuvant; Attachment (G) protein; Eosinophils; Respiratory syncytial virus (RSV); Subunit vaccines; T cells; Toll like receptor (TLR); Unmethylated CpG

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; QS 21; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

EID: 0346817398     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00482-1     Document Type: Article
Times cited : (36)

References (39)
  • 1
    • 0035927982 scopus 로고    scopus 로고
    • Respiratory syncytial virus and parainfluenza virus
    • Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:2001;1917-1928.
    • (2001) N. Engl. J. Med. , vol.344 , pp. 1917-1928
    • Hall, C.B.1
  • 2
    • 0036425594 scopus 로고    scopus 로고
    • What have we learned from the Tucson Children's Respiratory Study
    • Martinez F. What have we learned from the Tucson Children's Respiratory Study. Paediatr. Respir. Rev. 3:2002;193-197.
    • (2002) Paediatr. Respir. Rev. , vol.3 , pp. 193-197
    • Martinez, F.1
  • 3
    • 0036419092 scopus 로고    scopus 로고
    • A cohort of children hospitalized with acute RSV bronchiolitis: Impact on later respiratory disease
    • Sigurs N. A cohort of children hospitalized with acute RSV bronchiolitis: impact on later respiratory disease. Paediatr. Respir. Rev. 3:2002;177-183.
    • (2002) Paediatr. Respir. Rev. , vol.3 , pp. 177-183
    • Sigurs, N.1
  • 4
    • 0032926030 scopus 로고    scopus 로고
    • Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
    • Han L.L., Alexander J.P., Anderson L.J. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Inf. Dis. 179:1999;25-30.
    • (1999) J. Inf. Dis. , vol.179 , pp. 25-30
    • Han, L.L.1    Alexander, J.P.2    Anderson, L.J.3
  • 5
    • 0033949819 scopus 로고    scopus 로고
    • Respiratory syncytial virus infection in adults
    • Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:2000;371-384.
    • (2000) Clin. Microbiol. Rev. , vol.13 , pp. 371-384
    • Falsey, A.R.1    Walsh, E.E.2
  • 7
    • 0014493282 scopus 로고
    • An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine
    • Kapikian A.Z., Mitchell R.H., Chanock R.M., Shevdoff R.A., Stewart C.E. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1968;405-413.
    • (1968) Am. J. Epidemiol , vol.89 , pp. 405-413
    • Kapikian, A.Z.1    Mitchell, R.H.2    Chanock, R.M.3    Shevdoff, R.A.4    Stewart, C.E.5
  • 8
    • 0014495251 scopus 로고
    • Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
    • Kim H.W., Canchola J.G., Brandt C.D.et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:1969;422-434.
    • (1969) Am. J. Epidemiol. , vol.89 , pp. 422-434
    • Kim, H.W.1    Canchola, J.G.2    Brandt, C.D.3
  • 9
    • 0026460748 scopus 로고
    • Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells
    • Connors M., Kulkarni A.B., Firestone C.Y., Holmes K.L., Morse H.C. III, Sotnikov A.V.et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66:1992;7444-7451.
    • (1992) J. Virol , vol.66 , pp. 7444-7451
    • Connors, M.1    Kulkarni, A.B.2    Firestone, C.Y.3    Holmes, K.L.4    Morse H.C. III5    Sotnikov, A.V.6
  • 10
    • 0037120001 scopus 로고    scopus 로고
    • A role for immune complexes in enhanced respiratory syncytial virus disease
    • Polack F.P., Teng M.N., Collins P.L.et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J. Exp. Med. 196:2002;859-865.
    • (2002) J. Exp. Med. , vol.196 , pp. 859-865
    • Polack, F.P.1    Teng, M.N.2    Collins, P.L.3
  • 11
    • 0031848862 scopus 로고    scopus 로고
    • Respiratory syncytial virus vaccines
    • Dudas R.A., Karron R.A. Respiratory syncytial virus vaccines. Clin. Microbiol Rev. 11:1998;430-439.
    • (1998) Clin. Microbiol Rev. , vol.11 , pp. 430-439
    • Dudas, R.A.1    Karron, R.A.2
  • 12
    • 0032623340 scopus 로고    scopus 로고
    • Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics
    • Collins P.L., Whitehead S.S., Bukreyev A.et al. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res. 54:1999;423-451.
    • (1999) Adv. Virus Res. , vol.54 , pp. 423-451
    • Collins, P.L.1    Whitehead, S.S.2    Bukreyev, A.3
  • 13
    • 0029817240 scopus 로고    scopus 로고
    • Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus
    • Hancock G.E., Speelman D.J., Heers K., Bortell E., Smith J., Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus. J. Virol. 70:1996;7783-7791.
    • (1996) J. Virol. , vol.70 , pp. 7783-7791
    • Hancock, G.E.1    Speelman, D.J.2    Heers, K.3    Bortell, E.4    Smith, J.5    Cosco, C.6
  • 14
    • 0028902386 scopus 로고
    • Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection
    • Hancock G.E., Speelman D.J., Frenchick P.J., Mineo-Kuhn M.M., Baggs R.B., Hahn D.J. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine. 13:1995;391-400.
    • (1995) Vaccine , vol.13 , pp. 391-400
    • Hancock, G.E.1    Speelman, D.J.2    Frenchick, P.J.3    Mineo-Kuhn, M.M.4    Baggs, R.B.5    Hahn, D.J.6
  • 15
    • 0027402921 scopus 로고
    • Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins
    • Alwan W.H., Openshaw P.J. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine. 11:1993;431-437.
    • (1993) Vaccine , vol.11 , pp. 431-437
    • Alwan, W.H.1    Openshaw, P.J.2
  • 16
    • 0035860575 scopus 로고    scopus 로고
    • CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)
    • Hancock G.E., Heers K.M., Smith J.D., Scheuer C.A., Ibraghimov A.R., Pryharski K.S. CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV). Vaccine. 19:2001;4874-4882.
    • (2001) Vaccine , vol.19 , pp. 4874-4882
    • Hancock, G.E.1    Heers, K.M.2    Smith, J.D.3    Scheuer, C.A.4    Ibraghimov, A.R.5    Pryharski, K.S.6
  • 18
    • 0036604930 scopus 로고    scopus 로고
    • Control of adaptive immune responses by Toll-like receptors
    • Barton G.M., Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:2002;380-383.
    • (2002) Curr. Opin. Immunol , vol.14 , pp. 380-383
    • Barton, G.M.1    Medzhitov, R.2
  • 19
    • 0033580949 scopus 로고    scopus 로고
    • Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
    • Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
    • (1999) J. Biol. Chem. , vol.274 , pp. 17406-17409
    • Schwandner, R.1    Dziarski, R.2    Wesche, H.3    Rothe, M.4    Kirschning, C.J.5
  • 20
    • 0035909372 scopus 로고    scopus 로고
    • Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
    • Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
    • (2001) Nature , vol.413 , pp. 732-738
    • Alexopoulou, L.1    Holt, A.C.2    Medzhitov, R.3    Flavell, R.A.4
  • 21
    • 0033120081 scopus 로고    scopus 로고
    • Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product
    • Hoshino K., Takeuchi O., Kawai T.et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:1999;3749-3752.
    • (1999) J. Immunol , vol.162 , pp. 3749-3752
    • Hoshino, K.1    Takeuchi, O.2    Kawai, T.3
  • 22
    • 0028089006 scopus 로고
    • The pulmonary immune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus
    • Hancock G.E., Hahn D.J., Speelman D.J., Hildreth S.W., Pillai S., McQueen K. The pulmonary immune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus. Vaccine. 12:1994;267-274.
    • (1994) Vaccine , vol.12 , pp. 267-274
    • Hancock, G.E.1    Hahn, D.J.2    Speelman, D.J.3    Hildreth, S.W.4    Pillai, S.5    McQueen, K.6
  • 23
    • 0032890867 scopus 로고    scopus 로고
    • Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment
    • Domachowske J.B., Rosenberg H.F. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin. Microbiol. Rev. 12:1999;298-309.
    • (1999) Clin. Microbiol. Rev. , vol.12 , pp. 298-309
    • Domachowske, J.B.1    Rosenberg, H.F.2
  • 24
    • 0036065808 scopus 로고    scopus 로고
    • Further checkpoints in Th1 development
    • Robinson D.S., O'Garra A. Further checkpoints in Th1 development. Immunity. 16:2002;755-758.
    • (2002) Immunity , vol.16 , pp. 755-758
    • Robinson, D.S.1    O'Garra, A.2
  • 25
    • 0034098957 scopus 로고    scopus 로고
    • The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12
    • Hancock G.E., Smith J.D., Heers K.M. The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12. Viral Immunol. 13:2000;57-72.
    • (2000) Viral Immunol , vol.13 , pp. 57-72
    • Hancock, G.E.1    Smith, J.D.2    Heers, K.M.3
  • 26
    • 0031181334 scopus 로고    scopus 로고
    • IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness
    • Hussell T., Khan U., Openshaw P.J.M. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. J. Immunol. 159:1997;328.
    • (1997) J. Immunol. , vol.159 , pp. 328
    • Hussell, T.1    Khan, U.2    Openshaw, P.J.M.3
  • 27
    • 0029099861 scopus 로고
    • Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity
    • Tang Y.W., Graham B.S. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:1995;734.
    • (1995) J. Infect. Dis. , vol.172 , pp. 734
    • Tang, Y.W.1    Graham, B.S.2
  • 28
    • 0023707741 scopus 로고
    • Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies
    • Anderson L.J., Bingham P., Hierholzer J.C. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J. Virol. 62:1988;4232-4238.
    • (1988) J. Virol. , vol.62 , pp. 4232-4238
    • Anderson, L.J.1    Bingham, P.2    Hierholzer, J.C.3
  • 29
    • 0034080129 scopus 로고    scopus 로고
    • The serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines co-formulated with natural fusion and attachment proteins of respiratory syncytial virus
    • Hancock G.E., Smith J.D., Heers K.M. The serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines co-formulated with natural fusion and attachment proteins of respiratory syncytial virus. J. Inf. Dis. 181:2000;1768-1771.
    • (2000) J. Inf. Dis. , vol.181 , pp. 1768-1771
    • Hancock, G.E.1    Smith, J.D.2    Heers, K.M.3
  • 30
    • 0034507382 scopus 로고    scopus 로고
    • QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus
    • Hancock G.E., Heers K.M., Smith J.D. QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus. Viral Immunol. 13:2000;503-509.
    • (2000) Viral Immunol , vol.13 , pp. 503-509
    • Hancock, G.E.1    Heers, K.M.2    Smith, J.D.3
  • 31
    • 0037018097 scopus 로고    scopus 로고
    • Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity
    • Bendelac A., Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 4(195):2002;F19-F23.
    • (2002) J. Exp. Med. , vol.4 , Issue.195
    • Bendelac, A.1    Medzhitov, R.2
  • 33
    • 0024410891 scopus 로고
    • Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
    • Coffman R.L., Seymour B.W.P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:1989;308-310.
    • (1989) Science , vol.245 , pp. 308-310
    • Coffman, R.L.1    Seymour, B.W.P.2    Hudak, S.3    Jackson, J.4    Rennick, D.5
  • 34
    • 0025216937 scopus 로고
    • Lymphokine control of in vivo immunoglobulin isotype selection
    • Finkleman F.D., Holmes J., Katona I.M.et al. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8:1990;303.
    • (1990) Ann. Rev. Immunol , vol.8 , pp. 303
    • Finkleman, F.D.1    Holmes, J.2    Katona, I.M.3
  • 35
    • 0037083298 scopus 로고    scopus 로고
    • Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals
    • de Jong E.C., Vieira P.L., Kalinski P.et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168:2002;1704-1709.
    • (2002) J. Immunol , vol.168 , pp. 1704-1709
    • De Jong, E.C.1    Vieira, P.L.2    Kalinski, P.3
  • 36
    • 5944261457 scopus 로고    scopus 로고
    • Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
    • Kurt-Jones E.A., Popova L., Kwinn L.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
    • (2000) Nat. Immunol. , vol.1 , pp. 398-401
    • Kurt-Jones, E.A.1    Popova, L.2    Kwinn, L.3
  • 37
    • 0036164902 scopus 로고    scopus 로고
    • Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug
    • Oberholzer A., Oberholzer C., Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 30:2002;S58-S63.
    • (2002) Crit. Care Med. , vol.30
    • Oberholzer, A.1    Oberholzer, C.2    Moldawer, L.L.3
  • 38
    • 0031573220 scopus 로고    scopus 로고
    • Analysis of granuloma formation in double cytokine-deficient mice reveals a central role forIL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo
    • Wynn T.A., Morawetz R., Scharton-Kersten T.et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role forIL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159:1997;5014-5023.
    • (1997) J. Immunol. , vol.159 , pp. 5014-5023
    • Wynn, T.A.1    Morawetz, R.2    Scharton-Kersten, T.3
  • 39
    • 0035961452 scopus 로고    scopus 로고
    • Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
    • Prince G.A., Denamur F., Deschamps M.et al. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease. Vaccine. 19:2001;2048-2054.
    • (2001) Vaccine , vol.19 , pp. 2048-2054
    • Prince, G.A.1    Denamur, F.2    Deschamps, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.